ANIP: ANI Pharma P/S multiplikatori

ANI Pharma (ANIP) tovar belgisi

ANI Pharmaceuticals xodimlar xarajatlarini kamaytirish uchun qadoqlash va inkapsulyatsiya avtomatlashtirishini joriy qilmoqda. Kompaniya, shuningdek, mahsulotlarni ishlab chiqarish va dorixonalarga tarqatish uchun uchinchi tomon pudratchilaridan foydalanadi. Ushbu grafikda GURU.Markets ma'lumotlari aks etgan joriy P/S koeffitsiyenti 1.60 ushbu metrikaning joriy qiymatini belgilashi bilan xarakterlanadi. Firma generik dori vositalari ishlab chiqarishni serdaromad orfan dori vositalari savdosi bilan muvaffaqiyatli birlashtiradi.

ANIP (ANI Pharmaceuticals, Inc.) P/S multiplikatori tarixi 04.07.2022dan 13.11.2026gacha

ANI Pharma (ANIP) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi anipharmaceuticals.com|ANIP - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi haqida ma'lumot:
Bozor kapitallashuvi ANI Pharma|ANIP - Kompaniyaning to‘liq qiymati
- balans bo'yicha xususiy kapital ma'lumotlari:
Bitta aksiya hisobiga xususiy kapital ANI Pharmaceuticals|ANIP - Balans kapitallashuvi|Balans qiymatiga nisbatan bozor kapitallashuvi anipharmaceuticals.com|ANIP - Kompaniyaning yakuniy aktivlari
- emitentning kredit yuki va likvidlik ko'rsatkichlari:
Barcha qarzlarning o‘z mablag‘lariga nisbati ANI Pharmaceuticals|ANIP - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning o'z kapitaliga nisbati ANI Pharmaceuticals Corp|ANIP - Kompaniyaning jamlangan qarzlari|Qarzning sof aktivlarga nisbati ANI Pharma|ANIP - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari ANI Pharmaceuticals|Oraliq qoplash koeffitsiyenti anipharmaceuticals.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
ANIP - Kompaniyaning sof foydasi|Kelajakdagi foyda ANI Pharmaceuticals|ANIP - P/E multiplikatori|Forvard P/E multiplikatori ANI Pharmaceuticals Inc|ANIP - PEG multiplikatori|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati koeffitsiyenti ANI Pharma|ANIP - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda ANI Pharmaceuticals|ANIP - So'nggi 12 oy davomida bir aksiya uchun sof foyda|Choraklik EPS foyda o'sishi anipharmaceuticals.com|ANIP - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning prognoz qilingan ortishi ANI Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
ANIP - Daromad va sotish hajmi|Kompaniyaning kelajakdagi savdosi anipharmaceuticals.com|ANIP - P/S multiplikatori|Forvard narx/daromad multiplikatori ANI Pharma
Kompaniyaning umumiy tahlili:anipharmaceuticals.com, ANIP
ANI Pharmaceuticals Inc tayyor mahsulotlari

ANI Pharmaceuticals (ANIP) kompaniyasi uchun, u o'z ichki imkoniyatlarini GMP-standartidagi autsorsing ishlab chiqarish bilan birlashtiradi, P/S ko'rsatkichi daromad generatsiyasi samaradorligini baholashning asosiy vositasi bo'lib xizmat qiladi. Jori P/S bahosini tahlil qilish orqali investor bozor kapitalizatsiyasini haqiqiy savdo hajmi bilan solishtiradi, bu esa ularga spekulyativ shovqinlarni filtrlash va biznesning adolatli qiymatini uning operatsion ko'lamiga nisbatan aniqlash imkonini beradi.

Raqobatdosh kompaniyalar

HLN (haleon.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori KVUE (Kenvue)|P/S multiplikatori Verona Pharma PLC VRNA|MENS - Narxning daromadga nisbati|LGND (Ligand Corp) - Kapitalizatsiya va daromad nisbati|AMRX: P/S multiplikatori|PRGO - Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati ALVO|LQDA: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Galapagos Genomics (GLPG)|MNKD: Narxning sotuvga nisbati|P/S multiplikatori AMPH (Amphastar Pharmaceuticals)|Bozor kapitallashuvining daromadga nisbati PCRX|ARS Pharmaceuticals, Inc. - P/S multiplikatori|TBPH - P/S multiplikatori|Aquestive Pharma (AQST) - Narxning daromadga nisbati|scPharmaceuticals - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tectonic Therapeutic Inc.|Kapitalizatsiyaning daromadga nisbati tonixpharma.com (TNXP)|P/S multiplikatori SXTC|P/S multiplikatori eupraxiapharma.com (EPRX)|P/S multiplikatori BHST (BioHarvest)|EXOZ - Kapitalizatsiyaning daromadga nisbati|Oramed Pharma - P/S multiplikatori|Sotuvga nisbatan narx Entera Bio Ltd.|HYFT (MindWalk Holdings Inc.) - Kapitalizatsiyaning daromadga nisbati|ABVC BioPharma Inc. (ABVC) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati CPIX|QNTM (Quantum BioPharma Corp) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori FGEN|Narx/daromad koeffitsiyenti telomirpharma.com|P/S multiplikatori RANI (Rani Therapeutics Holdings, Inc.)|SNYR - Kapitalizatsiyaning daromadga nisbati|Rallybio Corp. - P/S multiplikatori|LEXX - P/S multiplikatori|Pulmatrix, Inc. (PULM) - Narxning daromadga nisbati|PTHL (Pheton Holdings) - Narxning daromadga nisbati|Narxning daromadga nisbati Aptorum Group Ltd|Lyra Therapeutics Inc. (LYRA) - Narx/daromad koeffitsiyenti|P/S multiplikatori IBO|P/S multiplikatori tnfpharma.com (TNFA)|Narxning daromadga nisbati cbdMD YCBD|PRFX: Kapitalizatsiya va daromad nisbati|Auris Medical - P/S multiplikatori|Narx/daromad koeffitsiyenti Lipella Pharmaceuticals Inc LIPO|Optinose (OPTN) - Narxning daromadga nisbati|Narxning sotuvga nisbati PIRS (Pieris Pharma)|Narxning daromadga nisbati Procaps Group S.A.|petrospharma.com - Narxning sotuvga nisbati|P/S multiplikatori QLI|SLRN (Acelyrin Inc.) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori TFFP (TFF Pharma)